Isovitexin Inhibits Ginkgolic Acids-Induced Inflammation Through Downregulating SHP2 Activation
Yiwei Zhang(Hubei University of Medicine), Xianying Fang(Nanjing Forestry University)
Cited by 25
Related Papers
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
|The Lancet Neurology|2019|185
Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells
|Bioconjugate Chemistry|2018|58